ROCKWELL MEDICAL, INC. Deferred Taxes, Business Combination, Valuation Allowance, Allocated to Contributed Capital
ROCKWELL MEDICAL, INC. (RMTI) had Deferred Taxes, Business Combination, Valuation Allowance, Allocated to Contributed Capital of $3.90 million as of 2022-12-31, per its 10-K filed 2023-03-30.
Discontinued › Notes › Income Taxes
us-gaap:DeferredTaxesBusinessCombinationValuationAllowanceAllocatedToContributedCapital · last filed 2023-03-30
- 2022-12-31: Deferred Taxes, Business Combination, Valuation Allowance, Allocated to Contributed Capital $3.90M.
- 2021-12-31: Deferred Taxes, Business Combination, Valuation Allowance, Allocated to Contributed Capital $4.20M.
- 2020-12-31: Deferred Taxes, Business Combination, Valuation Allowance, Allocated to Contributed Capital $4.20M.
- 2019-12-31: Deferred Taxes, Business Combination, Valuation Allowance, Allocated to Contributed Capital $3.80M.
| Period end | Deferred Taxes, Business Combination, Valuation Allowance, Allocated to Contributed Capital |
|---|---|
| 2022-12-31 | $3.90M 10-K · filed 2023-03-30 |
| 2021-12-31 | $4.20M 10-K · filed 2022-04-08 |
| 2020-12-31 | $4.20M 10-K · filed 2021-03-31 |
| 2019-12-31 | $3.80M 10-K · filed 2020-03-17 |
| 2018-12-31 | $3.30M 10-K · filed 2019-03-18 |
| 2017-12-31 | $3.00M 10-K · filed 2018-03-15 |
| 2016-12-31 | $5.40M 10-K · filed 2017-03-15 |
| 2015-12-31 | $7.10M 10-K · filed 2016-02-29 |
| 2014-12-31 | $7.30M 10-K · filed 2015-03-03 |
| 2013-12-31 | $3.70M 10-K · filed 2014-03-07 |
| 2012-12-31 | $2.40M 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B |